Redlight Guide

Temporomandibular disorder / jaw pain

Red light therapy for TMJ and jaw pain

Evidence on low-level laser therapy for temporomandibular disorders and jaw pain, including wavelength comparisons.

Study count

The cited reviews include 31 RCTs and a 27-RCT network meta-analysis with 969 TMD patients.

Evidence grade

moderate

Panel relevance

partially-replicable

Bottom line

TMJ/TMD evidence is stronger for targeted clinical laser use than for general red light panels held near the jaw.

Consensus: LLLT appears to improve TMD pain in meta-analyses, but wavelength, dose, and device geometry remain important and not fully settled.

What the studies found

  • A 2018 review of 31 RCTs found overall pain and function outcomes favored LLLT over placebo.
  • A 2022 network meta-analysis found all active LLLT wavelength groups improved pain compared with placebo.
  • The 910-1100 nm range ranked best in the 2022 network meta-analysis.

Dosage and timing

Wavelengths633, 672, 780, 904, 910, 1100 nm
IrradianceNot settled
FluenceNot settled
Session timeVaried by trial.
FrequencyVaried by trial.
DurationVaried by trial.
TimingNo strong time-of-day consensus.
Treatment areaTMJ region and painful masticatory muscle points.
Device typesClinical low-level laser therapy devices.
NotesA network meta-analysis ranked 910-1100 nm highest, which is outside many standard red/NIR panel wavelength sets.
  • There is no universal home-panel protocol.
  • Wavelength choice may matter, and the top-ranked wavelength range is not standard in common 660/850 nm panels.
  • Targeted clinical placement should be kept separate from general facial exposure.

Caveats

  • Jaw pain can involve dental, joint, muscular, and neurological causes.
  • TMD should not be self-diagnosed from an SEO article.
  • Clinical laser evidence should not be overextended to panel marketing claims.

Cited peer-reviewed sources

meta-analysis 31 included studies Evidence: moderate; direction: positive Panel relevance: partially-replicable Wavelengths: Not reported Dose/timing: Varied by trial / Varied by trial Area: Temporomandibular joint and related pain points Device: Low-level laser therapy Source

Xu GZ, Jia J, Jin L, et al. Pain Research and Management. 2018.

A review of TMD RCTs found pain and functional outcomes favored LLLT over placebo.

Source

meta-analysis 27 included studies Evidence: moderate; direction: positive Panel relevance: partially-replicable Wavelengths: 633, 672, 780, 904, 910, 1100 nm Dose/timing: Varied by trial / Varied by trial Area: Temporomandibular disorder pain sites Device: Low-level laser therapy and TENS comparators Source

Ren H, Liu J, Liu Y, et al. Journal of Oral Rehabilitation. 2022.

A network meta-analysis compared LLLT wavelength ranges and TENS for TMD pain.

Source

Last reviewed: 2026-06-15